Clinical trials
Ovarian Neoplasms trials in Italy with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute, Naples | 9 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 7 |
| Catholic University of the Sacred Heart | 4 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 4 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| Advenchen Laboratories, LLC | 1 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Sabine Rhode | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 33 |
| Breast Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Fallopian Tube Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Uterine Neoplasms | 2 |
| Adenomyosis | 1 |
| Anemia | 1 |
| Appendiceal Neoplasms | 1 |
| Ascites | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.